查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829938

2025年全球組織心臟瓣膜市場報告

Tissue Heart Valves Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，組織心臟瓣膜市場規模穩定成長，從2024年的14.8億美元增加至2025年的15.2億美元，複合年成長率為2.3%。預測期內的成長歸因於文明病盛行率的上升、醫療支出的增加、老年人口的成長、心臟及病理疾病的增多以及心臟病發病率的上升。

預計未來幾年組織心臟瓣膜市場規模將穩定成長，到2029年將達到16.8億美元，年複合成長率（CAGR）為2.6%。預測期內的成長可歸因於心血管疾病盛行率的上升、無縫線手術的日益普及、人口老化、心血管治療需求的不斷成長以及醫療保健投資的不斷增加。預測期內的主要趨勢包括技術創新、創新培養系統、影像技術的進步、手術技術的進步以及新興市場的擴張。

組織心臟瓣膜是用於人工心臟瓣膜置換術的生物心臟瓣膜，其設計功能類似天然心臟瓣膜，可取代機械心臟瓣膜。

組織心臟瓣膜主要分為帶支架和無支架兩種。帶支架組織心臟瓣膜是用金屬或聚合物框架（支架）加固的生物瓣膜，用於在瓣膜置換術中提供結構支撐並方便植入。這類瓣膜種類繁多，包括主動脈瓣、二尖瓣、三尖瓣和肺動脈瓣。它們被多種終端使用者使用，包括醫院、門診手術中心和其他醫療機構。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供組織心臟瓣膜市場統計數據，例如全球組織心臟瓣膜市場規模、各地區市場佔有率、競爭對手的市場佔有率、詳細的組織心臟瓣膜細分市場、市場趨勢和商業機會，為您提供在組織心臟瓣膜行業取得成功所需的數據。本組織心臟瓣膜市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

未來五年2.6%的預測成長率，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這可能會直接影響美國，導致來自澳洲和巴西等主要地區的牛心包組織和支架安裝零件供應鏈中斷，從而導致心臟瓣膜短缺。此外，由於互惠關稅以及貿易緊張局勢和限制措施加劇對全球經濟和貿易造成的負面影響，這一影響也將波及更廣泛的地區。

心血管疾病 (CVD) 的日益普及預計將在未來幾年推動組織心臟瓣膜市場的成長。心血管疾病 (CVD) 包括心臟病發作、中風和高血壓等疾病，是全球主要死因。這種成長主要是由於不健康的生活方式、人口老化、危險因素的增加、不良飲食、缺乏運動、吸煙、壓力和都市化，所有這些都導致​​了心臟相關疾病發病率的上升。組織心臟瓣膜在心血管疾病的置換術中發揮關鍵作用，它為需要瓣膜置換的患者提供了一種生物相容性、耐用且不易形成血栓的解決方案，最終改善長期心臟功能並減少併發症。例如，根據美國心臟衰竭協會 (HFSA) 2024 年 9 月的報告，大約有 670 萬 20 歲及以上的美國人患有心臟衰竭(HF)，預計到 2030 年這一數字將增加到 870 萬，到 2040 年將增加到 1030 萬，到 2050 萬增加到 140 萬。心血管疾病負擔的增加正在推動對組織心臟瓣膜的需求。

組織心臟瓣膜市場中的公司正專注於技術創新，以改善患者的治療效果。例如，2024年6月，總部位於愛爾蘭的科技公司美敦力公司推出了Avalus Ultra瓣膜，這是一款新一代外科主動脈組織瓣膜領先的有效孔口面積(EOA)，可改善血流。此外，該瓣膜包含一個滲透性線圈，以改善未來瓣中瓣手術中的可視性，並確保主動脈瓣狹窄患者的長期耐用性。

2024年2月，美國醫療設備製造商Foldax Inc.與Dolphin Life Sciences India LLP合作，在印度生產其Tria聚合物二尖瓣外科心臟瓣膜。此次合作將實現印度本土生產和分銷，使先進的心臟瓣膜解決方案更容易惠及患者。 Dolphin Life Sciences India LLP是一家專注於心臟瓣膜製造和分銷的印度生命科學公司。

組織心臟瓣膜市場包括豬異種移植瓣膜、牛心包瓣膜和自體瓣膜的銷售。該市場的價值指的是“出廠價”，即商品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的商品價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球心臟瓣膜機構市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球組織心臟瓣膜市場：成長率分析
  • 全球組織心臟瓣膜市場表現：規模與成長，2019-2024
  • 全球組織心臟瓣膜市場預測：規模與成長，2024-2029年，2034年
  • 全球組織心臟瓣膜：總目標市場（TAM）

第6章 市場細分

  • 全球組織心臟瓣膜市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 支架組織心臟瓣膜
  • 無支架組織心臟瓣膜
  • 全球組織心臟瓣膜市場（按瓣膜類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 主動脈
  • 二尖瓣
  • 三尖瓣
  • 肺
  • 全球組織心臟瓣膜市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心
  • 其他最終用戶
  • 全球組織心臟瓣膜市場：支架心臟瓣膜細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 牛
  • 豬肉瓣
  • 全球組織心臟瓣膜市場：無支架組織心臟瓣膜細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 牛無支架瓣膜
  • 同種異體瓣膜

第7章 區域和國家分析

  • 全球組織心臟瓣膜市場：區域表現及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球組織心臟瓣膜市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 組織心臟瓣膜市場：競爭格局
  • 組織心臟瓣膜市場：公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • LifeNet Health Inc.
  • TTK Healthcare Ltd.
  • Braile Biomedica
  • On-X Life Technologies Inc.
  • Anteris Technologies Ltd.
  • Labcor Laboratorios Ltd.
  • CARDION sro
  • CryoLife Inc.
  • Colibri Heart Valve LLC
  • Foldax Inc.
  • Balance Medical Technologies Co. Ltd.
  • MiCardia Corporation
  • Neovasc Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年組織心臟瓣膜市場：提供新機會的國家
  • 2029年組織心臟瓣膜市場：細分領域帶來新機會
  • 2029年組織心臟瓣膜市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r34168u

Tissue heart valves are biological heart valves used in replacement surgeries, designed to function such as natural heart valves as an alternative to mechanical ones.

The primary types of tissue heart valves are stented and stentless valves. Stented tissue heart valves are bioprosthetic valves reinforced with a metal or polymer frame (stent) to provide structural support and simplify implantation during valve replacement procedures. These valves come in various types, including aortic, mitral, tricuspid, and pulmonary valves. They are utilized by multiple end-users, such as hospitals, ambulatory surgical centers, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The tissue heart valves market research report is one of a series of new reports from The Business Research Company that provides tissue heart valves market statistics, including the tissue heart valves industry global market size, regional shares, competitors with the tissue heart valves market share, detailed tissue heart valves market segments, market trends, and opportunities, and any further data you may need to thrive in the tissue heart valves industry. This tissue heart valves market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue heart valves market size has grown steadily in recent years. It will grow from $1.48 billion in 2024 to $1.52 billion in 2025 at a compound annual growth rate (CAGR) of 2.3%. The growth in the historic period can be attributed to the growing prevalence of lifestyle diseases, rising healthcare expenditure, increasing elderly population, increase in cardiac & pathological disorders, and growing incidences of heart diseases.

The tissue heart valves market size is expected to see steady growth in the next few years. It will grow to $1.68 billion in 2029 at a compound annual growth rate (CAGR) of 2.6%. The growth in the forecast period can be attributed to the increasing prevalence of cardiovascular diseases, the rise in popularity of sutureless procedures, the growing aging population, the growing demand for cardiovascular treatments, and increasing healthcare investments. Major trends in the forecast period include technological innovations, innovative culture systems, advancements in imaging technologies, advancements in surgical techniques, and expansion in emerging market.

The forecast of 2.6% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for bovine pericardial tissue and stent mounting components, sourced from key regions such as Australia and Brazil, could lead to shortages in cardiac replacement valves.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiovascular diseases (CVDs) is expected to drive the growth of the tissue heart valves market in the coming years. CVDs, which include conditions such as heart attacks, strokes, and hypertension, are among the leading causes of mortality worldwide. This rise is primarily driven by unhealthy lifestyles, aging populations, increased prevalence of risk factors, poor diets, physical inactivity, smoking, stress, and urbanization, all contributing to higher rates of heart-related disorders. Tissue heart valves play a crucial role in treating cardiovascular diseases by offering a biocompatible, durable, and less thrombogenic solution for patients requiring valve replacement, ultimately improving long-term heart function and reducing complications. For example, in September 2024, a report by the Heart Failure Society of America (HFSA) stated that approximately 6.7 million Americans aged 20 and older are living with heart failure (HF), with projections estimating this number to rise to 8.7 million by 2030, 10.3 million by 2040, and 11.4 million by 2050. This rising burden of CVDs is fueling the demand for tissue heart valves.

Companies operating in the tissue heart valves market are focusing on technological innovations to improve patient outcomes. For instance, in June 2024, Medtronic plc, an Ireland-based technology company, launched the Avalus Ultra valve, a next-generation surgical aortic tissue valve designed to enhance ease of use during implantation and support long-term patient management. This valve, built on a decade of clinical experience with the Avalus valve, features a low profile, a polyetheretherketone (PEEK) base frame for consistent circularity, and an industry-leading Effective Orifice Area (EOA) to improve blood flow. Additionally, it includes a radiopaque coil for better visibility in future valve-in-valve procedures, ensuring long-term durability for patients with aortic stenosis.

In February 2024, Foldax Inc., a US-based medical device company, partnered with Dolphin Life Science India LLP to manufacture the Tria polymer mitral surgical heart valve in India. This collaboration enables in-country production and distribution, making advanced heart valve solutions more accessible to patients. Dolphin Life Science India LLP is an India-based life sciences company specializing in heart valve manufacturing and distribution.

Major players in the tissue heart valves market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Edwards Lifesciences Corporation, LivaNova PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, LifeNet Health Inc., TTK Healthcare Ltd., Braile Biomedica, On-X Life Technologies Inc., Anteris Technologies Ltd., Labcor Laboratorios Ltd., CARDION s.r.o., CryoLife Inc., Colibri Heart Valve LLC, Foldax Inc., Balance Medical Technologies Co. Ltd., MiCardia Corporation, Neovasc Inc.

North America was the largest region in the tissue heart valves market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tissue heart valves report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the tissue heart valves market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue heart valves market consists of sales of porcine xenograft valves, bovine pericardial valves, and autograft valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Heart Valves Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue heart valves market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue heart valves ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue heart valves market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Stented Tissue Heart Valves; Stentless Tissue Heart Valves
  • 2) By Valve Type: Aortic; Mitral; Tricuspid; Pulmonary
  • 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Stented Tissue Heart Valves: Bovine Pericardial Valves; Porcine Valves
  • 2) By Stentless Tissue Heart Valves: Bovine Pericardial Stentless Valves; Homograft Valves
  • Companies Mentioned: Abbott Laboratories; Medtronic PLC; Boston Scientific Corporation; Edwards Lifesciences Corporation; LivaNova PLC; Meril Life Sciences Pvt. Ltd.; MicroPort Scientific Corporation; LifeNet Health Inc.; TTK Healthcare Ltd.; Braile Biomedica; On-X Life Technologies Inc.; Anteris Technologies Ltd.; Labcor Laboratorios Ltd.; CARDION s.r.o.; CryoLife Inc.; Colibri Heart Valve LLC; Foldax Inc.; Balance Medical Technologies Co. Ltd.; MiCardia Corporation; Neovasc Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Heart Valves Market Characteristics

3. Tissue Heart Valves Market Trends And Strategies

4. Tissue Heart Valves Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tissue Heart Valves Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tissue Heart Valves PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tissue Heart Valves Market Growth Rate Analysis
  • 5.4. Global Tissue Heart Valves Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tissue Heart Valves Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tissue Heart Valves Total Addressable Market (TAM)

6. Tissue Heart Valves Market Segmentation

  • 6.1. Global Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Stented Tissue Heart Valves
  • Stentless Tissue Heart Valves
  • 6.2. Global Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Aortic
  • Mitral
  • Tricuspid
  • Pulmonary
  • 6.3. Global Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users
  • 6.4. Global Tissue Heart Valves Market, Sub-Segmentation Of Stented Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine Pericardial Valves
  • Porcine Valves
  • 6.5. Global Tissue Heart Valves Market, Sub-Segmentation Of Stentless Tissue Heart Valves, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bovine Pericardial Stentless Valves
  • Homograft Valves

7. Tissue Heart Valves Market Regional And Country Analysis

  • 7.1. Global Tissue Heart Valves Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tissue Heart Valves Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Heart Valves Market

  • 8.1. Asia-Pacific Tissue Heart Valves Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Heart Valves Market

  • 9.1. China Tissue Heart Valves Market Overview
  • 9.2. China Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Heart Valves Market

  • 10.1. India Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Heart Valves Market

  • 11.1. Japan Tissue Heart Valves Market Overview
  • 11.2. Japan Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Heart Valves Market

  • 12.1. Australia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Heart Valves Market

  • 13.1. Indonesia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Heart Valves Market

  • 14.1. South Korea Tissue Heart Valves Market Overview
  • 14.2. South Korea Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Heart Valves Market

  • 15.1. Western Europe Tissue Heart Valves Market Overview
  • 15.2. Western Europe Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Heart Valves Market

  • 16.1. UK Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Heart Valves Market

  • 17.1. Germany Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Heart Valves Market

  • 18.1. France Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Heart Valves Market

  • 19.1. Italy Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Heart Valves Market

  • 20.1. Spain Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Heart Valves Market

  • 21.1. Eastern Europe Tissue Heart Valves Market Overview
  • 21.2. Eastern Europe Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Heart Valves Market

  • 22.1. Russia Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Heart Valves Market

  • 23.1. North America Tissue Heart Valves Market Overview
  • 23.2. North America Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Heart Valves Market

  • 24.1. USA Tissue Heart Valves Market Overview
  • 24.2. USA Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Heart Valves Market

  • 25.1. Canada Tissue Heart Valves Market Overview
  • 25.2. Canada Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Heart Valves Market

  • 26.1. South America Tissue Heart Valves Market Overview
  • 26.2. South America Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Heart Valves Market

  • 27.1. Brazil Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Heart Valves Market

  • 28.1. Middle East Tissue Heart Valves Market Overview
  • 28.2. Middle East Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Heart Valves Market

  • 29.1. Africa Tissue Heart Valves Market Overview
  • 29.2. Africa Tissue Heart Valves Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tissue Heart Valves Market, Segmentation By Valve Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tissue Heart Valves Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Heart Valves Market Competitive Landscape And Company Profiles

  • 30.1. Tissue Heart Valves Market Competitive Landscape
  • 30.2. Tissue Heart Valves Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. LivaNova PLC Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Heart Valves Market Other Major And Innovative Companies

  • 31.1. Meril Life Sciences Pvt. Ltd.
  • 31.2. MicroPort Scientific Corporation
  • 31.3. LifeNet Health Inc.
  • 31.4. TTK Healthcare Ltd.
  • 31.5. Braile Biomedica
  • 31.6. On-X Life Technologies Inc.
  • 31.7. Anteris Technologies Ltd.
  • 31.8. Labcor Laboratorios Ltd.
  • 31.9. CARDION s.r.o.
  • 31.10. CryoLife Inc.
  • 31.11. Colibri Heart Valve LLC
  • 31.12. Foldax Inc.
  • 31.13. Balance Medical Technologies Co. Ltd.
  • 31.14. MiCardia Corporation
  • 31.15. Neovasc Inc.

32. Global Tissue Heart Valves Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Heart Valves Market

34. Recent Developments In The Tissue Heart Valves Market

35. Tissue Heart Valves Market High Potential Countries, Segments and Strategies

  • 35.1 Tissue Heart Valves Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tissue Heart Valves Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tissue Heart Valves Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer